-transparent.png){kind=logo}
@JCOOP_ASCO editorial on unique needs of end-of-life care for different blood cancers discusses: #pallheme improves QOL but less utilized in cancers. Contextualize Weisse et al study. More #pallheme research needed for lymphoma and myeloma in era of cell therapy.
| UI | MeSH Term | Description | Entries |
|---|
Related Publications
Mazie Tsang, and
Thomas W LeBlanc
March 2020,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
Mazie Tsang, and
Thomas W LeBlanc
April 2022,
Journal of palliative medicine,
Mazie Tsang, and
Thomas W LeBlanc
October 2017,
Oncotarget,
Mazie Tsang, and
Thomas W LeBlanc
May 2024,
European journal of haematology,
Mazie Tsang, and
Thomas W LeBlanc
January 2012,
Nursing outlook,
Mazie Tsang, and
Thomas W LeBlanc
February 2014,
The Journal of community and supportive oncology,
Mazie Tsang, and
Thomas W LeBlanc
January 2021,
Journal of palliative medicine,
Mazie Tsang, and
Thomas W LeBlanc
January 2002,
Journal of palliative care,
Mazie Tsang, and
Thomas W LeBlanc
January 2015,
Hematology. American Society of Hematology. Education Program,
Mazie Tsang, and
Thomas W LeBlanc
March 2020,
Expert review of hematology,
